يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Tatsuo Kimura"', وقت الاستعلام: 1.11s تنقيح النتائج
  1. 1
    Utility of Kyoto Classification of Gastritis in subjects with a high-negative titer of anti-Helicobacter pylori antibody during a medical check-up

    المؤلفون: Shusei Fukunaga, Yasuaki Nagami, Akinobu Nakata, Yasuhiro Fujiwara, Tetsuya Tanigawa, Norifumi Kawada, Toshio Watanabe, Fumio Tanaka, Yuji Nadatani, Koji Otani, Shinya Fukumoto, Tatsuo Kimura, Koichi Taira, Shuhei Hosomi, Noriko Kamata, Satoshi Kosaka, Yuji Matsumoto

    المصدر: Journal of Clinical Biochemistry and Nutrition

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Clinical Biochemistry, Medicine (miscellaneous), Kyoto Classification of Gastritis, Logistic regression, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, medical check-up, 030109 nutrition & dietetics, Nutrition and Dietetics, Helicobacter pylori, high-negative titer, Receiver operating characteristic, biology, business.industry, Odds ratio, bacterial infections and mycoses, biology.organism_classification, Confidence interval, Titer, anti-H. pylori antibody, biology.protein, Original Article, 030211 gastroenterology & hepatology, Gastritis, medicine.symptom, Antibody, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebdad8f55a6d5e34a705dee6163198c5Test
    https://doi.org/10.3164/jcbn.20-21Test


    أضف إلى المفضلة
  2. 2
    Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients withEGFR‐mutant non‐small cell lung cancer

    المؤلفون: Jun Oyanagi, Tetsuya Watanabe, Koichi Ogawa, Mitsuru Fukui, Hiroyasu Kaneda, Tomoya Kawaguchi, Yasuhiro Koh, Yoshiya Matsumoto, Tomohiro Suzumura, Tatsuo Kimura, Shigeki Mitsuoka, Kenji Sawa, Nobuyuki Yamamoto, Motohiro Izumi, Kazuhisa Asai

    المصدر: Cancer Science

    مصطلحات موضوعية: Male, 0301 basic medicine, epidermal growth factor receptor tyrosine kinase inhibitor, Cancer Research, Lung Neoplasms, Cell, Gastroenterology, B7-H1 Antigen, 0302 clinical medicine, Japan, Carcinoma, Non-Small-Cell Lung, Tumor Microenvironment, Medicine, Epidermal growth factor receptor, Aged, 80 and over, education.field_of_study, biology, Kinase, General Medicine, Middle Aged, ErbB Receptors, Treatment Outcome, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Immunohistochemistry, Original Article, Female, Programmed cell death 1 ligand 2, non‐small cell lung cancer, Adult, medicine.medical_specialty, CD8 Antigens, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Clinical Research, Internal medicine, Humans, Lung cancer, education, Protein Kinase Inhibitors, Aged, Retrospective Studies, Tumor microenvironment, business.industry, Original Articles, programmed cell death‐1 ligand‐1, Programmed Cell Death 1 Ligand 2 Protein, medicine.disease, programmed cell death‐1 ligand‐2, Survival Analysis, 030104 developmental biology, Mutation, biology.protein, business, CD8

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb74ba3d7bb8d4caf8b67643a7c49790Test
    https://doi.org/10.1111/cas.14156Test


    أضف إلى المفضلة
  3. 3
    Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer

    المؤلفون: Kazuhisa Asai, Naruo Yoshimura, Tomohiro Suzumura, Tetsuya Watanabe, Kazuto Hirata, Tatsuo Kimura, Naoki Yoshimoto, Yuko Kuwae, Shigeki Mitsuoka, Kenji Sawa, Yoshiya Matsumoto, Tomoya Kawaguchi, Norio Yamamoto

    المصدر: Internal Medicine

    مصطلحات موضوعية: Male, Oncology, Pathology, Lung Neoplasms, T790M resistance mutation, transbronchial lung biopsy, Case Report, Piperazines, T790M, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Osimertinib, 030212 general & internal medicine, Epidermal growth factor receptor, interstitial lung disease, Aniline Compounds, medicine.diagnostic_test, biology, Interstitial lung disease, General Medicine, respiratory system, ErbB Receptors, medicine.anatomical_structure, osimertinib, 030220 oncology & carcinogenesis, Erlotinib, medicine.drug, medicine.medical_specialty, Adenocarcinoma of Lung, Antineoplastic Agents, Adenocarcinoma, Erlotinib Hydrochloride, 03 medical and health sciences, Internal medicine, Internal Medicine, Humans, Lung cancer, Protein Kinase Inhibitors, non-small cell lung cancer, Aged, Acrylamides, Lung, business.industry, medicine.disease, respiratory tract diseases, Bronchoalveolar lavage, biology.protein, Neoplasm Recurrence, Local, Lung Diseases, Interstitial, epidermal growth factor receptor, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43382437790915e0ea0da3489013b7aTest
    https://doi.org/10.2169/internalmedicine.8467-16Test


    أضف إلى المفضلة
  4. 4
    Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

    المؤلفون: Kenji Sawa, Yoshiya Matsumoto, Tomohiro Suzumura, Nobuyuki Yamamoto, Mitsuru Fukui, Naoki Yoshimoto, Kazuhisa Asai, Hiroyasu Kaneda, Jun Oyanagi, Tetsuya Watanabe, Yasuhiro Koh, Tomoya Kawaguchi, Shigeki Mitsuoka, Kazuto Hirata, Tatsuo Kimura

    المصدر: Lung cancer (Amsterdam, Netherlands). 139

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.disease_cause, 03 medical and health sciences, T790M, 0302 clinical medicine, Mutation Rate, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Humans, Digital polymerase chain reaction, Epidermal growth factor receptor, Lung cancer, Allele frequency, Protein Kinase Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Mutation, biology, Receiver operating characteristic, business.industry, Middle Aged, medicine.disease, Prognosis, respiratory tract diseases, ErbB Receptors, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, biology.protein, Female, business, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79be99440294b0c71209d938fd46322bTest
    https://pubmed.ncbi.nlm.nih.gov/31751804Test


    أضف إلى المفضلة
  5. 5
    Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L)

    المؤلفون: Takashi Kijima, Hidetoshi Hayashi, Kazuhiko Nakagawa, Yoichi Nakanishi, Takashi Niwa, Tetsuya Oguri, Yoshihito Kogure, Katsuya Watanabe, Seiji Yano, Akira Ono, Naruo Yoshimura, Kazuhisa Asai, Yasutaka Chiba, Tomoya Kawaguchi, Tatsuo Kimura, Takashi Kasai, Nobuyuki Yamamoto, Hiroshi Tanaka, Hiroshige Yoshioka

    المصدر: Japanese journal of clinical oncology. 49(10)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, medicine.medical_treatment, Docetaxel, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, Disease-Free Survival, 03 medical and health sciences, Erlotinib Hydrochloride, 0302 clinical medicine, Planned Dose, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Radiology, Nuclear Medicine and imaging, Epidermal growth factor receptor, Protein Kinase Inhibitors, Aged, Chemotherapy, biology, business.industry, General Medicine, Middle Aged, medicine.disease, respiratory tract diseases, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, biology.protein, Female, Erlotinib, Neoplasm Recurrence, Local, business, Febrile neutropenia, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108eff608f4eb0bf85c6b47f03162cf4Test
    https://pubmed.ncbi.nlm.nih.gov/31242302Test


    أضف إلى المفضلة
  6. 6
    Abstract 4906: Association between low-frequency pretreatment EGFR T790M mutation and tumor immune microenvironment in patients with EGFR-mutated non-small cell lung cancer

    المؤلفون: Kazuhisa Asai, Mitsuru Fukui, Tomoya Kawaguchi, Shigeki Mitsuoka, Jun Oyanagi, Tetsuya Watanabe, Tatsuo Kimura, Kenji Sawa, Koichi Ogawa, Yasuhiro Koh, Nobuyuki Yamamoto, Hiroyasu Kaneda, Yoshiya Matsumoto, Motohiro Izumi, Tomohiro Suzumura

    المصدر: Cancer Research. 79:4906-4906

    مصطلحات موضوعية: Cancer Research, Mutation, biology, business.industry, Immune microenvironment, Cancer, EGFR T790M, medicine.disease, medicine.disease_cause, Oncology, Cancer research, biology.protein, Medicine, In patient, Non small cell, Antibody, business, Lung cancer

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c7b0e294201bec534e5e2f01681e674eTest
    https://doi.org/10.1158/1538-7445.am2019-4906Test


    أضف إلى المفضلة
  7. 7
    Prospective Assessment of Continuation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Pemetrexed

    المؤلفون: Shinzoh Kudoh, Kyoichi Okishio, Tomoya Kawaguchi, Naruo Yoshimura, Shigeki Mitsuoka, Masaji Kobayashi, Kazuto Hirata, Tatsuo Kimura, Haruko Daga, Tomonori Hirashima, Koji Takeda

    المصدر: Journal of Thoracic Oncology. 8(1):96-101

    مصطلحات موضوعية: Male, Oncology, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Guanine, Lung Neoplasms, Neutropenia, Kaplan-Meier Estimate, Pemetrexed, Infections, Disease-Free Survival, Erlotinib Hydrochloride, Gefitinib, Glutamates, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Confidence Intervals, medicine, Clinical endpoint, Humans, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Fatigue, Aged, Aged, 80 and over, Leukopenia, biology, business.industry, Anemia, Middle Aged, medicine.disease, Anorexia, respiratory tract diseases, ErbB Receptors, Drug Resistance, Neoplasm, Quinazolines, biology.protein, Female, Erlotinib, medicine.symptom, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b7def7dae13a4e19428bf0c6b9f2ffTest


    أضف إلى المفضلة
  8. 8
    Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR

    المؤلفون: Shun-ichi Isa, Takako Oka, Akihito Kubo, Hidenori Tanaka, Shinzoh Kudoh, Kazuhisa Asai, Kazuto Hirata, Tatsuo Kimura, Kuniomi Matsuura, Tomoya Kawaguchi, Kenji Sawa, Tetsuya Watanabe, Naruo Yoshimura, Shigeki Mitsuoka, Naoki Yoshimoto, Toshiyuki Nakai, Tomohiro Suzumura, Masato Uji

    المصدر: Expert opinion on pharmacotherapy. 17(2)

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Lung Neoplasms, Genotype, Afatinib, medicine.medical_treatment, Antineoplastic Agents, Docetaxel, Biomarkers, Pharmacological, Disease-Free Survival, 03 medical and health sciences, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Epidermal growth factor receptor, Lung cancer, neoplasms, Protein Kinase Inhibitors, Randomized Controlled Trials as Topic, Pharmacology, Chemotherapy, biology, business.industry, General Medicine, medicine.disease, respiratory tract diseases, ErbB Receptors, 030220 oncology & carcinogenesis, biology.protein, Quinazolines, Taxoids, Erlotinib, business, Tyrosine kinase, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f07a7ee3d9631c64fa0d9b16e029fe4Test
    https://pubmed.ncbi.nlm.nih.gov/26781399Test


    أضف إلى المفضلة
  9. 9
    Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

    المؤلفون: Tatsuo Kimura, Hidenori Tanaka, Kosei Yasumoto, Makoto Oda, Kazuya Kondoh, Tetsuya Mitsudomi, Hidetaka Uramoto, Yasushi Yatabe, Shinji Takeuchi, Seiji Yano, Shinzoh Kudoh, Hiroshi Nokihara, Masahiko Higashiyama, Yuichiro Ohe, Tadaaki Yamada, Junji Yoshida, Yuko Minami, Haruhiro Saito, Katsuyuki Kiura, Keisei Tachibana, Masayuki Noguchi, Jun Yokota

    المصدر: Journal of Thoracic Oncology. 6(12):2011-2017

    مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Lung Neoplasms, Drug resistance, T790M, Erlotinib Hydrochloride, Gefitinib, Japan, medicine, Humans, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Aged, 80 and over, biology, business.industry, Hepatocyte Growth Factor, Carcinoma, Gene Amplification, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, Molecular biology, respiratory tract diseases, ErbB Receptors, Oncology, Drug Resistance, Neoplasm, Mutation, biology.protein, Quinazolines, Hepatocyte growth factor, business, Tyrosine kinase, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be9655c436ae4fa627f36fc466529c5Test


    أضف إلى المفضلة
  10. 10
    Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs

    المؤلفون: André Fujita, Masaharu Nomura, Rui Yamaguchi, Hiroshi Nokihara, Hiroshi Nishihara, Kazuya Kondoh, Seiji Yano, Arinobu Tojo, Asuka Nakata, Seiya Imoto, Ryo Yoshida, Tomoyuki Higuchi, Yoshinori Tamada, Teppei Shimamura, Tatsuo Kimura, Masahiko Higashiyama, Mai Yamauchi, Noriko Gotoh, Satoru Miyano

    المصدر: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
    Universidade de São Paulo (USP)
    instacron:USP
    Scientific Reports

    مصطلحات موضوعية: Transcriptional Activation, Beta-catenin, Lung Neoplasms, Transcription, Genetic, DNA Mutational Analysis, Molecular Sequence Data, Mutation, Missense, Antineoplastic Agents, Adenocarcinoma, Article, T790M, Gefitinib, NEOPLASIAS PULMONARES, Cell Line, Tumor, medicine, Humans, Molecular Targeted Therapy, Lung cancer, Protein kinase B, Wnt Signaling Pathway, beta Catenin, Gene knockdown, Multidisciplinary, biology, Base Sequence, Wnt signaling pathway, medicine.disease, Up-Regulation, respiratory tract diseases, ErbB Receptors, Gene Expression Regulation, Neoplastic, Protein Transport, Drug Resistance, Neoplasm, biology.protein, Cancer research, Quinazolines, Phosphorylation, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3395b86ff5afac957450f90de9325679Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث